Literature DB >> 33412133

Challenges to Randomized Trials in Adult and Congenital Cardiac and Thoracic Surgery.

Mario Gaudino1, Joanna Chikwe2, Emilia Bagiella3, Stephen Fremes4, David R Jones5, Bryan Meyers6, Jane W Newburger7, Richard G Ohye8, Peter Sassalos8, Dennis Wigle9, Antonino Di Franco10.   

Abstract

Randomized trials in surgery face additional challenges compared with those in medicine. Some of the challenges are intrinsic to the nature of the field (eg, issues with blinding, learning curve and surgeons' experience, and difficulties in defining the appropriate timing for comparative trials). Other issues are related to the surgical culture, the attitude of surgeons toward randomized trials, and the lack of support by professional and national bodies. In this review, a group of investigators with experience in trials in congenital and adult cardiac and thoracic surgery discusses the key issues with surgical trials and suggests potential solutions.
Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33412133      PMCID: PMC9425119          DOI: 10.1016/j.athoracsur.2020.11.042

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   5.102


  53 in total

1.  Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.

Authors:  Jeffrey J Popma; G Michael Deeb; Steven J Yakubov; Mubashir Mumtaz; Hemal Gada; Daniel O'Hair; Tanvir Bajwa; John C Heiser; William Merhi; Neal S Kleiman; Judah Askew; Paul Sorajja; Joshua Rovin; Stanley J Chetcuti; David H Adams; Paul S Teirstein; George L Zorn; John K Forrest; Didier Tchétché; Jon Resar; Antony Walton; Nicolo Piazza; Basel Ramlawi; Newell Robinson; George Petrossian; Thomas G Gleason; Jae K Oh; Michael J Boulware; Hongyan Qiao; Andrew S Mugglin; Michael J Reardon
Journal:  N Engl J Med       Date:  2019-03-16       Impact factor: 91.245

2.  Transplant-Free Survival and Interventions at 6 Years in the SVR Trial.

Authors:  Jane W Newburger; Lynn A Sleeper; J William Gaynor; Danielle Hollenbeck-Pringle; Peter C Frommelt; Jennifer S Li; William T Mahle; Ismee A Williams; Andrew M Atz; Kristin M Burns; Shan Chen; James Cnota; Carolyn Dunbar-Masterson; Nancy S Ghanayem; Caren S Goldberg; Jeffrey P Jacobs; Alan B Lewis; Seema Mital; Christian Pizarro; Aaron Eckhauser; Paul Stark; Richard G Ohye
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

3.  Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Authors:  Nasser K Altorki; Xiaofei Wang; Dennis Wigle; Lin Gu; Gail Darling; Ahmad S Ashrafi; Rodney Landrenau; Daniel Miller; Moishe Liberman; David R Jones; Robert Keenan; Massimo Conti; Gavin Wright; Linda J Veit; Suresh S Ramalingam; Mohamed Kamel; Harvey I Pass; John D Mitchell; Thomas Stinchcombe; Everett Vokes; Leslie J Kohman
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

4.  The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.

Authors:  Stuart J Pocock; Cono A Ariti; Timothy J Collier; Duolao Wang
Journal:  Eur Heart J       Date:  2011-09-06       Impact factor: 29.983

5.  Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials.

Authors:  Andrew W Hoel; Ahmed Kayssi; Soma Brahmanandam; Michael Belkin; Michael S Conte; Louis L Nguyen
Journal:  J Vasc Surg       Date:  2009-08       Impact factor: 4.268

6.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy.

Authors:  Eric J Velazquez; Kerry L Lee; Robert H Jones; Hussein R Al-Khalidi; James A Hill; Julio A Panza; Robert E Michler; Robert O Bonow; Torsten Doenst; Mark C Petrie; Jae K Oh; Lilin She; Vanessa L Moore; Patrice Desvigne-Nickens; George Sopko; Jean L Rouleau
Journal:  N Engl J Med       Date:  2016-04-03       Impact factor: 91.245

7.  Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial.

Authors:  Jane W Newburger; Lynn A Sleeper; Peter C Frommelt; Gail D Pearson; William T Mahle; Shan Chen; Carolyn Dunbar-Masterson; Seema Mital; Ismee A Williams; Nancy S Ghanayem; Caren S Goldberg; Jeffrey P Jacobs; Catherine D Krawczeski; Alan B Lewis; Sara K Pasquali; Christian Pizarro; Peter J Gruber; Andrew M Atz; Svetlana Khaikin; J William Gaynor; Richard G Ohye
Journal:  Circulation       Date:  2014-04-04       Impact factor: 29.690

8.  American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer.

Authors:  Hiran C Fernando; Robert Timmerman
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-11       Impact factor: 5.209

9.  Evidence-Based Evaluation of the Ethics of Sham Surgery for Parkinson's Disease.

Authors:  Stephen Polgar; Sheeza Mohamed
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

10.  An old off-pump coronary artery bypass surgeon's reflections: A retrospective.

Authors:  Gianni D Angelini
Journal:  J Thorac Cardiovasc Surg       Date:  2018-10-10       Impact factor: 5.209

View more
  1 in total

1.  Reply: Only randomized trials can define the gold standard.

Authors:  Giovanni Jr Soletti; Mario Gaudino
Journal:  JTCVS Tech       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.